About Jena Bioscience
Jena Bioscience is a company based in Jena (Germany) founded in 1999 by Thomas Billert and Mathias Grun. The company has 43 employees. Jena Bioscience offers products and services including Nucleotides, Crystallography Screens, and PCR Master Mixes. Jena Bioscience operates in a competitive market with competitors including Abcam, Stem Cell Technologies, OriGene, Sangon Biotech and Meridian Bioscience, among others.
- Headquarter Jena, Germany
- Employees 43
- Founders Thomas Billert, Mathias Grun
- SectorsHealthcare
- Email••••••••
- Website jenabioscience.com
- Social LinkedIn Facebook Instagram
- Legal Name Jena Bioscience Gmbh
- InvestorsWacker Chemie
& 1 more
- Employee Count43
Products & Services of Jena Bioscience
Jena Bioscience offers a comprehensive portfolio of products and services, including Nucleotides, Crystallography Screens, and PCR Master Mixes.
Reagents for DNA and RNA synthesis in research applications
Kits to promote protein crystal formation for structural analysis
Formulations for efficient DNA amplification in laboratory settings
Funding Insights of Jena Bioscience
- Total Rounds 2
- Investors Count 2
All 2 funding rounds of Jena Bioscience with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep 2018 | – | Private Equity Round | – | – | |
| Jun 2015 | – | Grant | – | – |
2 investors in total: 2 institutional.
Investors in Jena Bioscience
Jena Bioscience has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include Wacker Chemie and European Commission.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Silicones, polymers, and bio-solutions are manufactured for various industries. | 1914 | wacker.com | Munich, Germany | |
Institution of the European Union responsible for upholding the EU treaties | 1958 | ec.europa.eu | Brussels, Belgium |
Investor details for Jena Bioscience
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Jena Bioscience
3 people are tracked at Jena Bioscience (3 in leadership); the tracked headcount is 43.
| Name | Role | Group |
|---|---|---|
Thomas Billert | Co-Founder & MD | Leadership |
Mathias Grun | Co-Founder & CEO | Leadership |
Mathias Grün | Chief Executive Officer | Leadership |
Complete people profiles for Jena Bioscience
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Jena Bioscience
3 dated milestones of Jena Bioscience across 19 years, from founding to its latest funding, stage changes and deals.
- Founded Jena Bioscience is founded.
- Funding First funding round.
- Funding Latest funding round, Private Equity Round,.
Competitors of Jena Bioscience
Jena Bioscience operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Abcam, Stem Cell Technologies, OriGene, Sangon Biotech and Meridian Bioscience, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| abcam.com | 1998 | Cambridge, United Kingdom | $78.8M | 405 | Biological reagents and antibodies are developed for life science research. | |
| stemcell.com | 1993 | Vancouver, Canada | $11.92M | 129 | Developer of cell culture media and ancillary reagents for life science research | |
| origene.com | 1996 | Rockville, United States | $69.55M | 141 | Proteins, antibodies, and molecular tools are manufactured for research applications. | |
| sangon.com | 2003 | Shanghai, China | $300M | – | Research services, reagents, and kits for biotech applications are provided. | |
| meridianbioscience.com | 1976 | Ohio, United States | – | – | Molecular diagnostic device and kits | |
| teknova.com | 1996 | Hollister, United States | – | 290 | Molecular biology reagents and kits are supplied for research applications. | |
| caymanchem.com | 1980 | Ann Arbor, United States | – | 309 | Bioreagents and assay kits are developed, with preclinical services provided. | |
| abclonal.com | 2006 | Woburn, United States | $281.25M | – | Developer of protein and peptide reagents and kits for cell and molecular biology research | |
| seracare.com | 1984 | Milford, United States | – | – | Provider of biological materials/products that help optimize diagnostic performance, reliability and repeatability |
Detailed competitors of Jena Bioscience
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Jena Bioscience
The website of Jena Bioscience (jenabioscience.com) receives about 47.7K visits a month.
- Monthly visits47.7K
▲ 12.4% vs previous month
Websites whose visitors overlap most with Jena Bioscience. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| qiagen.com | 100% | 458.2K | #105,023 | View details | |
hamptonresearch.com | hamptonresearch.com | 100% | – | #1,884,073 | – |
| stratagene.com | 99% | – | – | View details | |
| neb.com | 98% | 749.5K | #69,042 | View details | |
| clontech.com | 96% | – | – | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 40 similar websites and full traffic analytics for Jena Bioscience
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 40 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Latest news on Jena Bioscience
Complete news archive for Jena Bioscience
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to Jena Bioscience
10 companies that operate in the same segment as Jena Bioscience (Life Sciences Platforms & Tools), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | – | – | |
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | – | – | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.3 B | USD 301.49 M | 1,480 | |
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Biological reagents and antibodies are developed for life science research. | 1998 | Cambridge, Cambridgeshire, United Kingdom | USD 78.8 M | – | – | |
Electron microscopy services and microanalysis instruments are provided. | 1956 | Waltham, Massachusetts, United States | – | USD 44.56 B | 125,000 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
A platform for sharing and accessing academic research papers is provided. | 2008 | San Francisco, California, United States | USD 58.4 M | – | – | |
Developer of molecular diagnostic testing solutions | 1996 | Sunnyvale, California, United States | USD 19.1 M | USD 54.88 M | 208 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Jena Bioscience
Jena Bioscience was founded in 1999 and raised its 1st funding round 16 years after it was founded.
Jena Bioscience is headquartered in Jena, Germany. It is registered at Jena, Thuringia, Germany.
Mathias Grun is the current CEO of Jena Bioscience. They have also founded this company.
Jena Bioscience has 43 employees.
Jena Bioscience was founded in 1999 in Jena, Germany, focusing on the life science sector. Reagents and technologies are developed and manufactured, encompassing nucleosides, nucleotides, and non-natural analogs. Recombinant proteins, protein production systems, Click Chemistry reagents, and tools for biological macromolecule crystallization are also produced. Tailor-made solutions for molecular biology are provided to support research operations.
Jena Bioscience's top competitors include Abcam, Meridian Bioscience and Stem Cell Technologies.
Jena Bioscience offers Nucleotides, Crystallography Screens, and PCR Master Mixes.
Jena Bioscience has 2 investors. Key investors include Wacker Chemie, and European Commission.
Jena Bioscience operates through Jena Bioscience Gmbh.